Company Overview
Company Overview
The global rise in population age, extended lifespans, and the increasing prevalence of obesity and chronic conditions are driving the demand for advanced vascular health solutions.
Annually, over 20 million individuals worldwide face challenges such as strokes, post-surgical swelling, and non-healing wounds. Current therapies often fall short in addressing these issues, leaving patients at risk of further medical complications. Effective circulation management is crucial, as it can significantly influence the progression of associated diseases and conditions.
At the heart of geko’s™ mission is delivering innovative solutions for poor circulation, ensuring a safe recovery and accelerated healing.
Through advanced bioelectronic nerve stimulation technology, clinically validated to enhance blood circulation, we proudly introduce the award-winning geko™ device. Harnessing the body’s internal compression system—specific nerves and muscles—it provides a substantial, on-demand increase in blood flow, whether used in hospital settings or at home.
The geko™ device
The geko™ device surpasses limitations and stands out as a solution to meet critical needs where drugs and conventional compression devices are impractical or contraindicated.
Current methods such as external compression, multi-layer bandages, and drugs are the standard for enhancing blood circulation but are not universally effective. Intermittent pneumatic compression devices (IPC) and stockings often face compliance issues, while multi-layer bandaging can be challenging to apply and tolerate. Drugs, on the other hand, may carry unpredictable risks of bleeding.
This activation triggers the calf and foot muscle pumps, significantly increasing blood flow in the deep veins of the calf—at a rate equivalent to 60% of walking—without requiring the patient to move. This non-invasive approach alleviates strain on the cardiovascular and respiratory systems
By effectively reducing post-surgical complications and promoting accelerated healing, the geko™ device provides a safer recovery process.
The device mitigates post-operative swelling, particularly following knee, hip, or foot and ankle surgeries, and reduces the risk of dangerous blood clots, which is crucial for stroke patients. Furthermore, it accelerates wound healing in individuals with compromised circulation.
The geko™ device has demonstrated its clinical effectiveness through randomised controlled trials and real-world studies, leading to regulatory approval across multiple countries, including the US, Europe, the Middle East, and Asia.
Key opinion leaders now actively endorse and recommend the geko™ device, establishing it as a preferred choice in leading centres across 14 target countries, and it is now available in South Africa.
01
Oedema Reduction
Studies demonstrate that the geko™ device reduces post-operative swelling and pain and improves readiness for surgery by managing excessive pre-operative swelling.
02
Venous Thromboembolism (VTE):
The geko™ device provides preventive circulation therapy for all at-risk hospital patients, particularly those affected by acute stroke complications.
03
Wound Care
By significantly increasing lower limb blood flow, the geko™ device accelerates the healing of complex wounds.
References
- Science Daily. Mechanisms of impaired blood flow. September 2015.
- Tucker A. et al. Augmentation of venous, arterial and microvascular blood supply in the leg by isometric neuromuscular stimulation via the peroneal nerve. The International journal of angiology: 2010 Spring; 19(1): e31-7.
- Rabe E. et al. Risks and contraindications of medical compression treatment – A critical reappraisal. An international consensus statement. Phlebology – The journal of venous disease. March 2, 2020.
- Whiteley WN. et al. Targeted use of heparin, heparinoids, or low molecular-weight heparin to improve outcome after acute ischaemic stroke: An individual patient data meta-analysis of randomised controlled trials. The Lancet Neurology 2013;12, 539-545.
- Williams J. et al. The use of the geko™ device and the activation of the foot and calf pumps for prevention of venous thromboembolism in patients with acute stroke. Data on file, 2018. Firstkind Ltd.
- Baker P. Mahmood I. et al. James Cook Hospital. Data on file, April 2017, Firstkind Ltd.
- Wainwright W. et al. A feasibility randomised controlled trial to evaluate the effectiveness of a novel neuromuscular electro-stimulation device in preventing the formation of oedema following total hip replacement surgery. Heliyon, Volume 4. Issue 7, July 2018, e00697.
- Harris C. et al. Evaluation of a Muscle Pump-Activating Device for Non-Healing Venous Leg Ulcers. Int Wound J. 2017 Dec;14(6):1190-1198. DOI: 10.1111/iwj.12784. Epub 2017 Aug 2.
- NICE Guidelines (MTG19). Published date June 2014.
- Jones J. Harding K. et al. Neuromuscular electrostimulation on lower limb wounds. British Journal of Nursing Vol. 27, No. 20. Online: 12 Nov 2018.